Login / Signup

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial.

Adela Benítez-CanoSonia LuqueLuisa SorlíJesús CarazoIsabel RamosNuria CampilloVíctor CurullAlbert Sánchez-FontCarles VilaplanaJuan P HorcajadaRamón AdaliaSilvia BermejoEnric SamsóWilliam HopeSantiago Grau
Published in: Critical care (London, England) (2020)
The trial was registered in the European Union Drug Regulating Authorities Clinical Trials Database (EudraCT-no. 2016-002796-10). Registered on 27 December 2016.
Keyphrases
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • open label
  • adverse drug
  • acinetobacter baumannii
  • staphylococcus aureus
  • multidrug resistant
  • acute respiratory distress syndrome